Aequs Limited to host analyst meet at Avendus Spark Asia Edition

aequs management will participate in the Avendus Spark Asia Edition, an institutional investor conference held in Hong Kong on August 12, 2026. The meeting is scheduled to take place from 14:00 to 18:00 IST and will include both group sessions and one-on-one discussions with analysts and investors. This engagement aims to provide updates on the company’s strategic direction and operational performance to the investment community.

The intimation was filed pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Aequs Limited disclosed the details to the National Stock Exchange of India Limited and BSE Limited on August 09, 2026.

Event Details

The Avendus Spark Asia Edition will serve as a platform for direct interaction between Aequs Limited’s leadership and market participants. The format allows for broader dissemination of information through group meetings while also facilitating detailed queries via one-on-one sessions.

Date & Time	Event Name	Location	Nature of Meeting
August 12, 2026 14:00 – 18:00 HRS	Avendus Spark Asia Edition	Hong Kong	In Person - Group / One-on-One meet

Compliance and Disclosure

Ravi Mallikarjun Hugar, Company Secretary and Compliance Officer of Aequs Limited, signed the disclosure. The company emphasized that no Unpublished Price Sensitive Information (UPSI) will be shared or discussed during the conference. The schedule and participant list remain subject to change due to exigencies on the part of participants or the company.

What This Means for Investors

Participation in such analyst meets is a standard practice for listed entities to maintain transparency and engage with stakeholders. For investors, these events offer an opportunity to gauge management sentiment and clarify operational metrics directly with executives. The absence of UPSI ensures that all material information remains equally accessible to the broader market, maintaining regulatory compliance and fair disclosure practices.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+3.87%	+8.73%	+7.08%	+77.14%	+64.13%	+64.13%

Aequs Limited expanded its operational scope on August 07, 2026, when its Board of Directors approved alterations to Clause III(A) (Main Objects) of its Memorandum of Association. The changes are designed to align the company’s registered business activities with a proposed Scheme of Amalgamation involving three subsidiaries: Aerostructures Manufacturing India Private Limited, Aequs Engineered Plastics Private Limited, and Aequs Force Consumer Products Private Limited. This structural adjustment enables the company to formally engage in broader manufacturing sectors, including consumer products, precision engineering, and medical devices, following shareholder approval through a Postal Ballot process. The implementation remains subject to additional statutory and regulatory approvals.

The Board meeting commenced at 09:15 AM (IST) and concluded at 09:45 AM (IST) on August 07, 2026. In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company notified the National Stock Exchange of India Limited and BSE Limited. The disclosure also adhered to SEBI Circular No SEBI/HO/CFD/PoD2/I/3762/2026 dated January 30, 2026. Ravi Mallikarjun Hugar, Company Secretary and Compliance Officer, signed the intimation.

Expanded Business Objects

The alteration inserts Clauses 5 to 10 into the Main Objects section of the Memorandum of Association. These new clauses broaden the company’s permissible activities beyond its existing core operations. The specific additions include:

Clause	Business Activity Description
Clause 5	Manufacturing and trading of plastic materials (polythene, polypropylene, ABS, nylon, etc.) for industrial components, automobile parts, and aircraft accessories.
Clause 6	Manufacturing and trading of consumer products, including cookware, kitchenware, appliances, and electronic products made from metal, plastic, or other substances.
Clause 7	Development and manufacturing of high-precision engineering products, smart device components, and parts using precision molding methods.
Clause 8	Manufacturing and dealing in diverse consumer products such as toys, games, monuments, and articles made from various natural or synthetic materials.
Clause 9	Manufacturing and trading of medical instruments, equipment, disposable surgical tools, and allied medical appliances for healthcare and diagnosis.
Clause 10	Reiteration of consumer product manufacturing, focusing on electric, electronic, and non-electronic products for domestic, commercial, and industrial use.

Strategic Implications

The inclusion of these clauses signals a strategic diversification into high-growth sectors such as consumer durables and medical devices. By formally registering these objects, Aequs Limited positions itself to leverage the capabilities of its subsidiaries post-amalgamation without requiring further charter amendments for each new product line. The approval by shareholders via Postal Ballot indicates strong internal support for this consolidation strategy. However, the finalization of the amalgamation depends on securing remaining statutory and regulatory clearances, which are not yet confirmed in the filing.